Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases

被引：36
|
作者：
Qu, Yuan [1 ]
Liu, Yi [2 ]
Noor, Ahmed Fayyaz [3 ]
Tran, Johnathan [4 ]
Li, Rui [1 ]
机构：
[1] Jilin Univ, Dept Hand Surg, Hosp 2, Changchun, Jilin, Peoples R China
[2] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan, Shandong, Peoples R China
[3] Univ Massachusetts, Dept Chem, Lowell, MA USA
[4] Massachusetts Coll Pharm & Hlth Sci, Dept Premed & Hlth Studies, Boston, MA USA
来源：
NEURAL REGENERATION RESEARCH | 2019年 / 14卷 / 06期
关键词：
nerve regeneration; central nervous system; gene therapy; neurodegenerative disease; viral vector; adeno-associated virus; Alzheimer's disease; Parkinson's disease; Huntington's disease; amyotrophic lateral sclerosis; spinal muscular atrophy; neural regeneration; MUSCULAR-ATROPHY PHENOTYPE; MOUSE MODEL; ALZHEIMERS-DISEASE; CANAVAN-DISEASE; VIRAL VECTORS; DOUBLE-BLIND; AAV VECTORS; SPINAL-CORD; DELIVERY; BRAIN;
D O I：
10.4103/1673-5374.250570
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or gene correction provides the potential for transformative therapies to delay or possibly stop further progression of the neurodegenerative disease in affected patients. Adeno-associated virus has been the vector of choice in recent clinical trials of therapies for neurodegenerative diseases due to its safety and efficiency in mediating gene transfer to the central nervous system. This review aims to discuss and summarize the progress and clinical applications of adeno-associated virus in neurodegenerative disease in central nervous system. Results from some clinical trials and successful cases of central neurodegenerative diseases deserve further study and exploration.
引用
收藏
页码：931 / 938
页数：8
相关论文
共 50 条
  • [31] Adeno-associated virus vectors for gene therapy of neurodegenerative disorders
    During, MJ
    Leone, P
    CLINICAL NEUROSCIENCE, 1996, 3 (05) : 292 - 300
  • [32] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Michael F. Naso
    Brian Tomkowicz
    William L. Perry
    William R. Strohl
    BioDrugs, 2017, 31 : 317 - 334
  • [33] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Naso, Michael F.
    Tomkowicz, Brian
    Perry, William L., III
    Strohl, William R.
    BIODRUGS, 2017, 31 (04) : 317 - 334
  • [34] The adeno-associated virus vector for orthopaedic gene therapy
    Schwarz, EM
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) : S31 - S39
  • [35] A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy
    Lipinski, Daniel M.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2019, 1185 : 79 - 83
  • [36] Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death
    Okada, T
    Shimazaki, K
    Nomoto, T
    Matsushita, T
    Mizukami, H
    Urabe, M
    Hanazono, Y
    Kume, A
    Tobita, K
    Ozawa, K
    Kawai, N
    GENE THERAPY METHODS, 2002, 346 : 378 - 393
  • [37] Gene Therapy for Colon Cancer by Adeno-Associated Viral Vector-Mediated Transfer of Apolipoprotein(a) Kringles
    Lee, Kyuhyun
    Yun, Seong-Tae
    Lee, Hong-Kyu
    Jo, Eui-Cheol
    MOLECULAR THERAPY, 2006, 13 : S361 - S361
  • [38] Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice
    Takahashi, H
    Kato, K
    Miyake, K
    Hirai, Y
    Yoshino, S
    Shimada, I
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 455 - 461
  • [39] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. J., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2006, 13 (17) : 1281 - 1289
  • [40] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    D D Koeberl
    B D Sun
    T V Damodaran
    T Brown
    D S Millington
    D K Benjamin
    A Bird
    A Schneider
    S Hillman
    M Jackson
    R M Beaty
    Y T Chen
    Gene Therapy, 2006, 13 : 1281 - 1289
12345